Corrigendum to intimation of H2 FY2026 Investor Conference Call- Withdrawal of Scheduled Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shelter Pharma Ltd has cancelled the Investor Conference Call that was originally scheduled for Wednesday, 10th June 2026 to discuss H2 FY2026 results. The company cited 'unavoidable circumstances' as the reason for the withdrawal. This is a corrigendum to the earlier intimation submitted to BSE on 5th June 2026. The company has stated that a revised date for the conference call will be communicated separately in due course.
No direct financial impact, but investors awaiting management commentary on H2 FY2026 will have to wait for the rescheduled call. This may create minor short-term uncertainty around the timing of investor engagement.